Octreotide
- Traffic LightAmber (SCG)
- BNF8.3.4.3
- Licensed IndicatorsAcromegaly, carcinoid tumours/syndrome. If recommended by the palliative care team. Relief of symptoms from neuroendcrine tumours. Including long-acting formulations.
- Reference
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?